Germany is the first EU country to establish a compassionate psilocybin use program — a regulated expanded-access pathway ...

The program is tailored to meet the needs of aspiring researchers, lecturers, and mid-career professionals who seek to advance their research skills while remaining actively involved in their ...

Swiss study shows 60% of migrant HIV diagnoses are made post-arrival, challenging assumptions about when infections actually ...

Insilico will participate in BIO-Europe 2025 in Vienna, where it will introduce its new cardiometabolic drug portfolio and ...